US Patent Litigations are now available. Check here

EP3489211

NOVARTIS
Application Number
EP19151232A
Filing Date
May 12, 2011
Status
Revoked
Jan 18, 2025
Grant Date
Jul 15, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3489211B1 was granted on Jul 15, 2020 by Novartis The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2008043774
N/A
OppositionJPS6116171
N/A
OppositionCN1810744
N/A
OppositionCN101597204
N/A
OppositionWO2008142175
N/A
OppositionWO2010004193
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.